Chemogenomic Screening in a Patient‐Derived 3D Fatty Liver Disease Model Reveals the CHRM1‐TRPM8 Axis as a Novel Module for Targeted Intervention

JSON

Youhanna S, Kemas AM, Wright SC, Zhong Y, Klumpp B, Klein K, Motso A, Michel M, Ziegler N, Shang M, Sabatier P, Kannt A, Sheng H, Oliva‐Vilarnau N, Büttner FA, Seashore‐Ludlow B, Schreiner J, Windbergs M, Cornillet M, Björkström NK, Hülsmeier AJ, Hornemann T, Olsen JV, Wang Y, Gramignoli R, Sundström M, Lauschke VM

Adv Sci (Weinh) 12 (3) - [2025-01-00; online 2024-11-28]

Chemical Biology Consortium Sweden (CBCS) [Service]

DOI 10.1002/advs.202407572

Crossref 10.1002/advs.202407572